-+ 0.00%
-+ 0.00%
-+ 0.00%

Kiniksa Chief Strategy Officer Eben Tessari resigns to pursue new role

PUBT·05/01/2026 20:34:55
Listen to the news
Kiniksa Chief Strategy Officer Eben Tessari resigns to pursue new role
  • Kiniksa Pharmaceuticals said Chief Strategy Officer Eben Tessari will resign to pursue another executive role in life sciences.
  • Tessari will leave May 15, 2026.
  • He will remain involved as a consultant to Kiniksa.
  • Tessari will also serve as an advisor to Kiniksa’s Science and Research Committee.
  • Consulting arrangement runs from May 15, 2026 to May 15, 2027, with a one-year renewal option by mutual agreement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiniksa Pharmaceuticals International plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001730430-26-000021), on May 01, 2026, and is solely responsible for the information contained therein.